Revive Therapeutics Inc. (OTCMKTS: RVVTF) has signed a research partnership agreement with clinical psychedelics biotechnology firm PharmaTher Holdings Ltd. (OTCMKTS: PHRRF) to evaluate psilocybin delivery using...
Revive Therapeutics Ltd (OTCMKTS:RVVTF) acquired IP to Psilocybin of PharmaTher Inc., which is a subsidiary of Newscope Capital Corporation (OTCMKTS:PHRRF), for CAD 10 million. Revive Therapeutics...